Oruka Therapeutics (ORKA) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.83% |
| Dec 31, 2025 | -271.45% |
| Sep 30, 2025 | 241.53% |
| Jun 30, 2025 | -183.06% |
| Mar 31, 2025 | 106.30% |
| Dec 31, 2024 | -188.26% |
| Sep 30, 2024 | 3,235.43% |
| Jun 30, 2024 | -145.50% |
| Mar 31, 2024 | 2,727.18% |
| Dec 31, 2023 | 36.73% |
| Sep 30, 2023 | -140.49% |
| Jun 30, 2023 | 56.49% |
| Mar 31, 2023 | -6.76% |
| Dec 31, 2022 | 40.19% |
| Sep 30, 2022 | 4.73% |
| Jun 30, 2022 | 39.02% |
| Mar 31, 2022 | 13.20% |
| Dec 31, 2021 | -1.43% |
| Sep 30, 2021 | -30.73% |
| Jun 30, 2021 | -120.92% |
| Mar 31, 2021 | 982.51% |
| Dec 31, 2020 | -105.05% |
| Sep 30, 2020 | 3,932.92% |
| Jun 30, 2020 | 38.13% |
| Mar 31, 2020 | -31.75% |
| Dec 31, 2019 | -301.88% |
| Sep 30, 2019 | -116.28% |
| Jun 30, 2019 | 40.20% |
| Mar 31, 2019 | 196.55% |
| Dec 31, 2018 | 8.30% |
| Sep 30, 2018 | 35.84% |
| Jun 30, 2018 | -172.51% |
| Mar 31, 2018 | 506.07% |
| Dec 31, 2017 | 158.39% |
| Sep 30, 2017 | -132.72% |
| Jun 30, 2017 | 338.10% |
| Mar 31, 2017 | -77.38% |
| Dec 31, 2016 | 88.96% |
| Sep 30, 2016 | 59.03% |
| Jun 30, 2016 | -68.83% |
| Mar 31, 2016 | -238.99% |
| Dec 31, 2015 | -2.92% |
| Sep 30, 2015 | -108.16% |
| Jun 30, 2015 | 1,106.37% |
| Mar 31, 2015 | -67.28% |
| Dec 31, 2014 | 10.95% |
| Sep 30, 2014 | -16.92% |
| Jun 30, 2014 | -140.94% |
| Mar 31, 2014 | 336.99% |
| Dec 31, 2013 | -7.69% |
| Sep 30, 2013 | -110.35% |
| Jun 30, 2013 | 2,628.85% |
| Mar 31, 2013 | 480.86% |
| Dec 31, 2012 | -60.40% |
| Sep 30, 2012 | 90.33% |
| Jun 30, 2012 | 39.16% |
| Mar 31, 2012 | -980.00% |
| Dec 31, 2011 | 111.37% |
| Sep 30, 2011 | 18.60% |
| Jun 30, 2011 | -8.61% |
| Mar 31, 2011 | -120.20% |
| Dec 31, 2010 | 56.19% |